Chong Yang

Title: Innovations of Chong Yang in Colorectal Cancer Treatment

Introduction

Chong Yang is an accomplished inventor based in Shandong, China. He has made significant contributions to the field of biomedical research, particularly in the development of treatments for colorectal cancer and related conditions. His innovative work focuses on the creation of a myricetin derivative that has promising applications in medical science.

Latest Patents

Chong Yang holds a patent for a myricetin derivative and its preparation method. This invention is aimed at treating colitis, preventing and treating colitis-associated tumorigenesis, and addressing colorectal cancer. The myricetin derivative boasts excellent water solubility and demonstrates biological activities that include the inhibition of colitis and the prevention of tumorigenesis. The preparation method utilizes myricetrin as a starting material, which is both economical and readily available. This method is characterized by low cost, high yield, and high product purity, making it suitable for large-scale industrial production. The patent represents significant market value and economic prospects.

Career Highlights

Chong Yang is affiliated with the Marine Biomedical Research Institute of Qingdao Co., Ltd. His work at this institute has allowed him to focus on innovative research that addresses critical health issues. His dedication to advancing medical treatments is evident in his patent and ongoing research efforts.

Collaborations

Chong Yang collaborates with notable colleagues, including Feng Li and Shixiao Wang. Their combined expertise contributes to the advancement of research in the biomedical field.

Conclusion

Chong Yang's innovative contributions to the treatment of colorectal cancer through his myricetin derivative patent highlight his role as a significant inventor in the biomedical research community. His work not only addresses pressing health challenges but also holds promise for future advancements in medical treatments.